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Does your area of research use shared datasets?
• Re-using data has many benefits, including research synergy and efficient resource use
• Some research areas have tools, communities, and practices which facilitate re-use 
• Identifying these areas will allow us to learn from them, and apply the lessons 
to areas which underutilize the sharing and re-purposing of scientific data between investigators
Hope 
Identifying areas of particularly successful 
microarray data re-use -- such as Saccharomyces
cerevisiae datasets and studies of promoter regions 
and evolution -- can highlight best practices to be 
used when developing research agendas, tools, 
standards, repositories, and communities in areas 
which have yet to receive major benefits from shared 
data. 
Future Work
We plan to refine our prototype NLP tool for 
identifying studies which re-use data, and continue 
studying and measuring re-use and reusability.
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FIGURE 1: Documents with re-used data 
have a different MeSH distribution than those 
with original data.
Which datasets?
This study examines the data re-use of microarray gene expression datasets.  
Thousands of microarray gene expression datasets have been deposited in publicly available databases.
Many studies reuse this data, but it is not well understood which datasets are reused and for what purpose.
Here, we examined all publications in PubMed Central on April 1, 2007 containing the word 
“microarray.”
How did we identify re-use?
We trained a machine-learning algorithm to automatically classify full-text gene expression microarray 
studies into two classes: those that generated original microarray data (n=900) and those which only re-
used data (n=250).
SVlite, NLTK, feature selection
How did we identify patterns of re-use?
We then compared the Medical Subject Heading (MeSH) terms of two classes to identify MeSH topics 
which were over- or under-represented by publications with re-used data.
Results 
Studies on humans, mice, chordata, and invertebrates were roughly equally likely to be conducted using 
original or shared microarray data, whereas shared data was used in a relatively high proportion of studies 
involving fungi (odds ratio (OR)=2.4), and a relatively low proportion involving rats, bacteria, viruses, 
plants, or genetically-altered or inbred animals (OR<0.5). Unsurprisingly, when we looked at Major 
MeSH terms to represent the primary purpose of the studies, statistical and computational methods clearly 
dominated. The only biomedical topics with a relatively high proportion of data reuse Major MeSH terms 
were Promoter Regions, Evolution, and Protein Interaction Mapping. 
FIGURE 2: As expected, journals with a 
bioinformatics focus published the highest proportion of 
studies with re-used microarray data.
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FIGURE 3: The change in odds that a specific MeSH
term will describe a publication with re-used data as 
compared to a publication with original microarray data 
is illustrated in the Odds Ratio graphs above.
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